Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

References for Moyamoya Disease in Children

This page was last updated on November 25th, 2022

  1. Ahn IM, Park DH, Hann HJ, , et al: Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45:1090-1095, 2014
  2. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900-904, 2008
  3. Bang OY, Lee JS, Lee PH, , et al: Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882, 2005
  4. Bekelis K, Connolly ID, Do HM,  et al: Operative volume and outcomes of cerebrovascular neurosurgery in children. J Neurosurg Pediatr 18:623-628, 2016
  5. Blauwblomme T, Mathon B, Naggara O, et al: Long-term Outcome After Multiple Burr Hole Surgery in Children With Moyamoya Angiopathy: A Single-Center Experience in 108 Hemispheres. Neurosurgery 80:950-956, 2017
  6. Cecchi AC, Guo D, Ren Z, et al: RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke 45:3200-3207, 2014
  7. Chae JK, Kim I, Lim ST, et al: Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20:2573-2578, 2000
  8. Endo M, Kawano N, Miyaska Y, et al: Cranial burr hole for revascularization in moyamoya disease. J Neurosurg 71:180-185, 1989
  9. Fujimura M, Kaneta T, Mugikura S, et al: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273-282, 2007
  10. Fukui M, Kono S, Sueishi K, et al: Moyamoya disease. Neuropathology 20 Suppl:S61-64, 2000
  11. Fullerton HJ, Wintermark M, Hills NK, et al: Risk of Recurrent Arterial Ischemic Stroke in Childhood: A Prospective International Study. Stroke 47:53-59, 2016
  12. Funaki T, Takahashi JC, Houkin K, et al: Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128:777-784, 2018
  13. Fung LW, Thompson D, Ganesan V: Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 21:358-364, 2005
  14. Gaillard J, Klein J, Duran D, et al Incidence, clinical features, and treatment of familial moyamoya in pediatric patients: a single-institution series. J Neurosurg Pediatr 19:553-559, 2017
  15. Ganesan V, Smith ER: Moyamoya: defining current knowledge gaps. Dev Med Child Neurol 57:786-787, 2015
  16. Guey S, Tournier-Lasserve E, et al: Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49-68, 2015
  17. Guzman R, Steinberg GK: Direct bypass techniques for the treatment of pediatric moyamoya disease. Neurosurg Clin N Am 21:565-573, 2010
  18. Hall EM, Leonard J, Smith JL, et al: Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy. Pediatr Blood Cancer 63:1431-1437, 2016
  19. Houkin K, Kuroda S, Ishikawa T, et al: Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease? Acta Neurochir (Wien) 142:269-276, 2000
  20. Ikeda K, Iwasaki Y, Kashihara H, et al: Adult moyamoya disease in the asymptomatic Japanese population. J Clin Neurosci 13:334-338, 2006
  21. Im SH, Oh CW, Kwon OK, et al: Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg 102:1013-1017, 2005
  22. Jackson EM, Lin N, Manjila S, et al: Pial synangiosis in patients with moyamoya younger than 2 years of age. J Neurosurg Pediatr 13:420-425, 2014
  23. Karasawa J, Kikuchi H, Furuse S, et al: A surgical treatment of “moyamoya” disease “encephalo-myo synangiosis”. Neurol Med Chir (Tokyo) 17:29-37, 1977
  24. Kawabori M, Kuroda S, Nakayama N, et al: Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease. World Neurosurg 80:612-619, 2013
  25. Kim DS, Kang SG, Yoo DS, et al: Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results. Clin Neurol Neurosurg 109:125-131, 2007
  26. Kim JE, Oh CW, Kwon OK, et al: Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25:580-586, 2008
  27. Kim SK, Seol HJ, Cho BK, et al: Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840-844; discussion 844-846, 2004
  28. Kim SK, Wang KC, Kim IO, et al: Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery 50:88-96, 2002
  29. Kinugasa K, Mandai S, Tokunaga K, et al: Ribbon enchephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surg Neurol 41:455-461, 1994
  30. Kitahara T, Ariga N, Yamaura A, et al: Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry 42:208-214, 1979
  31. Komatsu K, Mikami T, Noshiro S, et al: Reversibility of White Matter Hyperintensity by Revascularization Surgery in Moyamoya Disease. J Stroke Cerebrovasc Dis 25:1495-1502, 2016
  32. Komura S, Mikami T, Sugino T, et al: Complementary Relation Between Direct and Indirect Bypass in Progress of Collateral Circulation in Moyamoya Disease. World Neurosurg 104:197-204, 2017
  33. Kudo T TR, Mikawakuchi K: Occlusion of internal carotid artery. Brain Nerve (Tokyo) 9:757, 1957
  34. Kuriyama S, Kusaka Y, Fujimura M, et al: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42-47, 2008
  35. Kuroda S, Kashiwazaki D, Hirata K, et al: Effects of surgical revascularization on cerebral oxygen metabolism in patients with Moyamoya disease: an 15O-gas positron emission tomographic study. Stroke 45:2717-2721, 2014
  36. Kusaka N, Sugiu K, Tokunaga K, et al: Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103:882-890, 2005
  37. Lee JY, Phi JH, Wang KC, et al: Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis 31:230-237, 2011
  38. Lee MJ, Chen YF, Fan PC, et al: Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan. J Neurol Sci 353:161-165, 2015
  39. Lin N, Baird L, Koss M, et al: Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg Focus 31:E6, 2011
  40. Macyszyn L, Attiah M, Ma TS, et al: Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. J Neurosurg 126:1523-1529, 2017
  41. Masuda J, Ogata J, Yutani C: Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24:1960-1967, 1993
  42. Matsuda Y, Mineharu Y, Kimura M, et al: RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease. J Stroke Cerebrovasc Dis 26:1841-1847, 2017
  43. Matsushima Y, Fukai N, Tanaka K, et al: A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol 15:313-320, 1981
  44. Miskinyte S, Butler MG, et al: Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 88:718-728, 2011
  45. Miyamoto S, Yoshimoto T, Hashimoto N, et al Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45:1415-1421, 2014
  46. Munot P, Saunders DE, Milewicz DM, et al: A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain 135:2506-2514, 2012
  47. Ng J, Thompson D, Lumley JP, et al: Surgical revascularisation for childhood moyamoya. Childs Nerv Syst 28:1041-1048, 2012
  48. Oki K HH, Suzuki N, et al.: Database count of the Research Committee on Spontaneous Occlusion of the Circle of Willis (moyamoya disease), in Hashimoto N (ed): A summarized report of 2005-2007 of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease). Kyoto, Japan: The Research Committee on Spontaneous Occlusion of the Circle of Willis (moyamoya disease), 2008, pp 15-20
  49. Sasaki R SS, Tamakoshi A, et al.: Clinicoepidemiological features of Spontaneous Occlusion of the Circle of Willis from a nationwide epidemiological survey, in Yanagawa H (ed): Annual Report of Epidemiology of Intractable Diseases Research Committee. Tochigi, Japan: The Research Committee on Epidemiology of Intractable Diseases, 1991, pp 30-32
  50. Scott RM, Smith JL, Robertson RL, et al.: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100:142-149, 2004
  51. Smith ER, McClain CD, Heeney M, et al.: Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 26:E10, 2009
  52. Storey A, Scott RM, Robertson R, et al.: Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. J Neurosurg Pediatr 19:289-295, 2017
  53. Suzuki J, Takaku A: Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288-299, 1969
  54. Taguchi A, Soma T, Tanaka H, et al: Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338, 2004
  55. Takahashi JC, Funaki T, Houkin K, et al: Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial. Stroke 47:37-43, 2016
  56. Takahashi JC IT, Iihara K, Miyamoto S: A nationwide survey on pregnancy and delivery management in association with moyamoya disease. Japanese Journal of Neurosurgery (Tokyo) 18:367-375, 2009
  57. Takeuchi K, Shimizu K: Hypoplasia of the bilateral internal carotid arteries. Brain Nerve (Tokyo) 9:37-43, 1957
  58. Titsworth WL, Scott RM, Smith ER: National Analysis of 2454 Pediatric Moyamoya Admissions and the Effect of Hospital Volume on Outcomes. Stroke 47:1303-1311, 2016
  59. Uchino K, Johnston SC, Becker KJ, et al: Moyamoya disease in Washington State and California. Neurology 65:956-958, 2005
  60. Vendrame M, Kaleyias J, Loddenkemper T, Smith E, McClain C, Rockoff M, et al: Electroencephalogram monitoring during intracranial surgery for moyamoya disease. Pediatric neurology 44:427-432, 2011
  61. Wakai K, Tamakoshi A, Ikezaki K, et al: Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 Suppl 2:S1-5, 1997
  62. Wallace S, Guo DC, Regalado E, et al: Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clin Genet 90:351-360, 2016
  63. Yang W, Xu R, Porras JL, et al: Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome. J Neurosurg Pediatr 20:232-238, 2017
  64. Yano A, Shingo T, Takeuchi A, et al: Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103:104-114, 2005
  65. Yoshimura S, Morishita R, Hayashi K, et al: Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 39:1028-1034, 2002
  66. Wang KC, Phi JH, Lee JY, et al. Indirect revascularization surgery for moyamoya disease in children and its special considerations. Korean J Pediatr 55:408-[RA1] 413, 2012

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.